companyNewsغير مصنف

GSK evaluating possibility of using vaccine technology for Zika

Jan 25 (Reuters) – GlaxoSmithKline Plc is concluding “feasibility” studies to see if its vaccine technology might be suitable for the Zika virus, a company spokeswoman told Reuters.

اظهر المزيد

مقالات ذات صلة

زر الذهاب إلى الأعلى